10 | TCRI 46% v1,18M c.0389 f70,9M H.042 big day off | znewcar1 | 07/12/2021 4:26:16 PM |
9 | RMDM 0.0001 Stock Charts $RMDM 1 Month Chart | chartguy89 | 03/09/2014 2:02:51 PM |
8 | RMDM Stock Charts Last: UNCH Saturday, March 1, | chartguy89 | 03/01/2014 9:54:12 AM |
7 | DTC has suspended all services, except Custody | LW | 09/18/2012 6:08:23 PM |
6 | You mean someone actually bought 2 mill shares of | Lmoney | 08/02/2012 4:51:36 PM |
5 | Just patiently waiting to get pass this mess and | Lmoney | 07/29/2012 9:04:03 PM |
4 | yup! Someone needs to pony up cash. We dont take | MMG | 07/29/2012 8:00:46 PM |
3 | Um well lets see,its been 3 long years.Sick of | Lmoney | 07/29/2012 10:13:19 AM |
2 | Theres a hige TA and State bill. China wont pay. | MMG | 07/27/2012 7:32:25 AM |
1 | Mini Mar Marketing Group Newsletter | LW | 04/14/2012 1:01:16 AM |
Recent Articles
- U.S. Energy Corp.'s Participation in the Roth Conference Event
- Semtech Corporation Investors Have Class Action Opportunity
- ServiceTitan Reports Strong Growth and Future Plans for 2025
- Canterbury Park Holding Corporation Declares Cash Dividend for Shareholders
- Roy D. Baynes Joins Nurix Therapeutics Board of Directors
- Generation Bio's Innovative Approaches to Autoimmune Disease Therapy
- Investing in Vertex Pharmaceuticals: Growth and Returns Explained
- Shimmick Corporation Financial Update for Fiscal Year 2024
- Senti Bio Welcomes Feng Hsiung to Board of Directors
- Cognition Therapeutics Prepares for Year-End Financial Results
- Canada Foundation for Innovation Investments Boost Research Capacity
- Sutro Biopharma's 2024 Financial Review in Oncology Advancements
- Gaia, Inc. Set to Engage Investors at the Annual ROTH Conference
- Shuttle Pharmaceuticals Secures $5.75 Million Funding
- U.S. Energy Corp. Engages with Investors at Roth Conference
- 21Shares Plans to Wind Down Two Cryptocurrency ETFs Soon
- Astera Labs Enhances PCIe 6.x Interoperability for AI Growth
- Parsons Corporation Highlights Technological Innovations Ahead
- The Joint Corp. Shows Strong Growth in Recent Financials
- Sutro Biopharma Emphasizes Innovative ADC Pipeline Development
- Tailored Brands Welcomes New Leadership for Future Growth
- Oxford Industries Plans Exciting Q4 Results Release and Call
- Unveiling the Merger Investigation of Endo, Inc. - NDOI
- Maximizing the Value of Your Employee Benefit Plan Audit
- M&T Bank Corporation to Highlight Q1 2025 Earnings Insights
- Cognition Therapeutics Plans to Share 2024 Financial Results
- Docusign's Financial Growth in Fiscal Year 2025 Explained
- Understanding Virgin Galactic's Options Activity Surge
- REGENXBIO's 2024 Results Highlight Growth and Future Plans
- Enliven Therapeutics Showcases Promising Progress in 2024
- Purple Innovation Explores Strategic Alternatives for Growth
- Vuzix Corporation's Recent Performance Insights and Outlook
- AAR CORP. Set to Release Q3 Fiscal Results and Insights
- Purple Innovation's Year-End Financial Review and Future Outlook
- 100% Chiropractic's Leadership Change Promises Growth Ahead
- Intensity Therapeutics Celebrates Promising Developments in Cancer Therapy
- Recovering Investor Losses: A Guide for Block, Inc. Stakeholders
- Pacira BioSciences: Class Action Deadline Approaches for Investors
- Taking Control: FTAI Aviation Investors Seek Justice Today
- Blüm Holdings Showcases Growth in 2024 Annual Report Summary
- Novo Nordisk A/S: Addressing Investor Concerns and Lawsuits
- ESSA Pharma Inc. Legal Guidance for Investors' Recovery Options
- Ripple's Legal Showdown: The Future Classification of XRP
- REsides Boosts Shareholder Dividends and Investment Prospects
- TransDigm Group: Analyzing Market Sentiment Through Short Interest
- Understanding Gilead Sciences' Market Performance Dynamics
- Market Insights: Evaluating CACI International's Stock Sentiment
- Celebrating Cybersecurity Excellence: 2025 Globee Awards Winners
- Celebrating Community Impact: Alex Anzures' Humanitarian Journey
- Heritage Financial Earns Prestigious Barron's Recognition